211 related articles for article (PubMed ID: 17937233)
1. Cognitive outcome following brain injury and treatment with an inhibitor of Nogo-A in association with an attenuated downregulation of hippocampal growth-associated protein-43 expression.
Marklund N; Bareyre FM; Royo NC; Thompson HJ; Mir AK; Grady MS; Schwab ME; McIntosh TK
J Neurosurg; 2007 Oct; 107(4):844-53. PubMed ID: 17937233
[TBL] [Abstract][Full Text] [Related]
2. Delayed inhibition of Nogo-A does not alter injury-induced axonal sprouting but enhances recovery of cognitive function following experimental traumatic brain injury in rats.
Lenzlinger PM; Shimizu S; Marklund N; Thompson HJ; Schwab ME; Saatman KE; Hoover RC; Bareyre FM; Motta M; Luginbuhl A; Pape R; Clouse AK; Morganti-Kossmann C; McIntosh TK
Neuroscience; 2005; 134(3):1047-56. PubMed ID: 15979242
[TBL] [Abstract][Full Text] [Related]
3. Tissue sparing and functional recovery following experimental traumatic brain injury is provided by treatment with an anti-myelin-associated glycoprotein antibody.
Thompson HJ; Marklund N; LeBold DG; Morales DM; Keck CA; Vinson M; Royo NC; Grundy R; McIntosh TK
Eur J Neurosci; 2006 Dec; 24(11):3063-72. PubMed ID: 17156367
[TBL] [Abstract][Full Text] [Related]
4. Progesterone alters Nogo-A, GFAP and GAP-43 expression in a rat model of traumatic brain injury.
Liu F; Liao F; Li W; Han Y; Liao D
Mol Med Rep; 2014 Apr; 9(4):1225-31. PubMed ID: 24567055
[TBL] [Abstract][Full Text] [Related]
5. Exercise normalizes levels of MAG and Nogo-A growth inhibitors after brain trauma.
Chytrova G; Ying Z; Gomez-Pinilla F
Eur J Neurosci; 2008 Jan; 27(1):1-11. PubMed ID: 18093178
[TBL] [Abstract][Full Text] [Related]
6. Anti-Nogo-A antibody infusion 24 hours after experimental stroke improved behavioral outcome and corticospinal plasticity in normotensive and spontaneously hypertensive rats.
Wiessner C; Bareyre FM; Allegrini PR; Mir AK; Frentzel S; Zurini M; Schnell L; Oertle T; Schwab ME
J Cereb Blood Flow Metab; 2003 Feb; 23(2):154-65. PubMed ID: 12571447
[TBL] [Abstract][Full Text] [Related]
7. Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice.
Marklund N; Morales D; Clausen F; Hånell A; Kiwanuka O; Pitkänen A; Gimbel DA; Philipson O; Lannfelt L; Hillered L; Strittmatter SM; McIntosh TK
Neuroscience; 2009 Oct; 163(2):540-51. PubMed ID: 19555742
[TBL] [Abstract][Full Text] [Related]
8. Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat.
Marklund N; Fulp CT; Shimizu S; Puri R; McMillan A; Strittmatter SM; McIntosh TK
Exp Neurol; 2006 Jan; 197(1):70-83. PubMed ID: 16321384
[TBL] [Abstract][Full Text] [Related]
9. Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice.
Hånell A; Clausen F; Björk M; Jansson K; Philipson O; Nilsson LN; Hillered L; Weinreb PH; Lee D; McIntosh TK; Gimbel DA; Strittmatter SM; Marklund N
J Neurotrauma; 2010 Jul; 27(7):1297-309. PubMed ID: 20486800
[TBL] [Abstract][Full Text] [Related]
10. Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression.
Chao PK; Lu KT; Jhu JY; Wo YY; Huang TC; Ro LS; Yang YL
J Neuroinflammation; 2012 Jun; 9():121. PubMed ID: 22676811
[TBL] [Abstract][Full Text] [Related]
11. Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1.
Fouad K; Klusman I; Schwab ME
Eur J Neurosci; 2004 Nov; 20(9):2479-82. PubMed ID: 15525289
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of myelin-associated inhibitors and their receptors after traumatic brain injury in the mouse.
Israelsson C; Flygt J; Åstrand E; Kiwanuka O; Bengtsson H; Marklund N
Restor Neurol Neurosci; 2014; 32(5):717-31. PubMed ID: 25079982
[TBL] [Abstract][Full Text] [Related]
13. Alpha tocopherol treatment reduces the expression of Nogo-A and NgR in rat brain after traumatic brain injury.
Yang J; Han Y; Ye W; Liu F; Zhuang K; Wu G
J Surg Res; 2013 Jun; 182(2):e69-77. PubMed ID: 23207171
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats.
Mahmood A; Wu H; Qu C; Mahmood S; Xiong Y; Kaplan D; Chopp M
Brain Res; 2014 Jan; 1542():41-8. PubMed ID: 24177046
[TBL] [Abstract][Full Text] [Related]
15. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
Yang G; Tang WY
Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
[TBL] [Abstract][Full Text] [Related]
16. Delayed anti-nogo-a antibody application after spinal cord injury shows progressive loss of responsiveness.
Gonzenbach RR; Zoerner B; Schnell L; Weinmann O; Mir AK; Schwab ME
J Neurotrauma; 2012 Feb; 29(3):567-78. PubMed ID: 21815784
[TBL] [Abstract][Full Text] [Related]
17. [Effect of ventricle injection of Nogo-A antibody on neuronal regeneration following hypoxic-ischemic brain damage in the neonatal rat].
Zhou XG; Liu RH; Xiong AH
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Aug; 9(4):301-4. PubMed ID: 17706025
[TBL] [Abstract][Full Text] [Related]
18. Administration of monoclonal antibodies neutralizing the inflammatory mediators tumor necrosis factor alpha and interleukin -6 does not attenuate acute behavioral deficits following experimental traumatic brain injury in the rat.
Marklund N; Keck C; Hoover R; Soltesz K; Millard M; LeBold D; Spangler Z; Banning A; Benson J; McIntosh TK
Restor Neurol Neurosci; 2005; 23(1):31-42. PubMed ID: 15846030
[TBL] [Abstract][Full Text] [Related]
19. Neutralization of the membrane protein Nogo-A enhances growth and reactive sprouting in established organotypic hippocampal slice cultures.
Craveiro LM; Hakkoum D; Weinmann O; Montani L; Stoppini L; Schwab ME
Eur J Neurosci; 2008 Nov; 28(9):1808-24. PubMed ID: 18973596
[TBL] [Abstract][Full Text] [Related]
20. Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury.
Zhu J; Hamm RJ; Reeves TM; Povlishock JT; Phillips LL
Exp Neurol; 2000 Nov; 166(1):136-52. PubMed ID: 11031090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
